NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Clinical trials for NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart drug hope: can sotagliflozin help HCM patients breathe easier?
Symptom relief Recruiting nowThis study tests an investigational drug called sotagliflozin in 500 adults with hypertrophic cardiomyopathy (HCM) who still have symptoms like shortness of breath or chest pain. Participants will receive either the drug or a placebo for 26 weeks. The main goal is to see if the d…
Matched conditions: NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE3 • Sponsor: Lexicon Pharmaceuticals • Aim: Symptom relief
Last updated May 17, 2026 11:37 UTC
-
New heart drug aims to give patients with thick heart muscle more energy and less shortness of breath
Symptom relief Recruiting nowThis study tests an experimental drug called ninerafaxstat in 165 adults with a type of thickened heart muscle that blocks blood flow only during exercise (non-obstructive HCM). Participants will receive either the drug or a placebo on top of their usual care. The goal is to see …
Matched conditions: NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Imbria Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC